Benefit evaluation in multiple sclerosis relapse treatment from the patients’ perspective – Development and validation of a new questionnaire
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 28, 256-261
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01EH1101B)
This publication has 21 references indexed in Scilit:
- The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) RegistryBMC Neurology, 2013
- Burden of a Multiple Sclerosis RelapseThe Patient - Patient-Centered Outcomes Research, 2012
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: A clarification of its contentBMC Medical Research Methodology, 2010
- Responsiveness of patient-based and external rating scales in multiple sclerosis: Head-to-head comparison in three clinical settingsJournal of the Neurological Sciences, 2010
- Assessing disability progression with the Multiple Sclerosis Functional CompositeMultiple Sclerosis Journal, 2009
- The emotional and psychological impact of multiple sclerosis relapsesJournal of the Neurological Sciences, 2007
- Die deutsche Version des EuroQol-FragebogensJournal of Public Health, 1998
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Rating neurologic impairment in multiple sclerosisNeurology, 1983